Compounds > thiazolyl blue
Page last updated: 2024-08-24

thiazolyl blue and Animal Mammary Carcinoma

thiazolyl blue has been researched along with Animal Mammary Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argano, M; Buracco, P; De Maria, R; Menzies, MPL; Rodlsberger, K1
Batlle, A; Casas, A; Di Venosa, G; Fukuda, H1
Bally, MB; Chia, S; Denyssevych, T; Dragowska, WH; Gelmon, K; Masin, D; Wallis, AE; Warburton, C; Yan, H1

Other Studies

3 other study(ies) available for thiazolyl blue and Animal Mammary Carcinoma

ArticleYear
Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2019, Volume: 83, Issue:2

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Colorimetry; Coloring Agents; Dog Diseases; Dogs; Female; Hypnotics and Sedatives; Mammary Neoplasms, Animal; Propofol; Tetrazolium Salts; Thiazoles

2019
In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
    Cellular and molecular biology (Noisy-le-Grand, France), 2002, Volume: 48, Issue:8

    Topics: Acridine Orange; Adenocarcinoma; Animals; Apoptosis; Coloring Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorescent Dyes; Light; Mammary Neoplasms, Animal; Mice; Microscopy, Fluorescence; Oxygen; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Time Factors; Tryptophan; Tumor Cells, Cultured; Verteporfin

2002
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Apr-01, Volume: 10, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, SCID; Neoplasm Transplantation; Phosphorylation; Quinazolines; Receptor, ErbB-2; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Time Factors; Trastuzumab

2004